-
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Monday, May 12, 2025 - 4:32am | 1100Read More...On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the “most consequential executive order” in U.S. history, aimed at lowering prescription drug prices. What Happened: Trump said the executive order, set to be signed at 9 a.m. Monday, will...
-
Mark Cuban Vows To Revamp US Healthcare By Empowering Independent Pharmacies: 'We Don't Want To See Pharmacy Deserts.
Friday, March 28, 2025 - 3:48am | 492Read More...Billionaire investor and entrepreneur Mark Cuban is taking strides to overhaul the U.S. healthcare sector, beginning with his venture, Cost Plus Drugs. What Happened: Cuban shared his vision of revamping healthcare in the nation in a recent conversation with The Hill. The “Shark...
-
Trump Picks Dr. Oz As Centers For Medicare And Medicaid Services Administrator
Tuesday, November 19, 2024 - 6:27pm | 497Read More...President-elect Donald Trump on Tuesday said he will nominate celebrity physician Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services (CMS). The Details: Trump announced Dr. Oz as his pick for CMS administrator in a statement Tuesday afternoon. "Our broken Healthcare System...
-
4 Reasons Raymond James Likes Addus Homecare
Monday, August 20, 2018 - 3:29pm | 379Read More...Addus Homecare Corporation (NASDAQ: ADUS), a provider of home care services across 25 states, should be bought even though it's already "pricey," according to Raymond James. The Analyst Raymond James' John Ransom initiated coverage of Addus Homecare with an Outperform rating and $...
-
Analyst: Buy CRH Medical After An 'Overdone' Selloff
Monday, July 17, 2017 - 11:40am | 361Read More...CRH Medical Corp (NYSE: CRHM)'s 27 percent plunge on Friday in reaction to rate changes by the Medicare & Medicaid Services (CMS) is overdone and investors should consider buying shares on the weakness, Cannacord Genuity's Richard Close said in a report. The proposed changes by the CMS...
-
The Latest On Drug Pricing, Healthcare Bill As Senate Takes Up Issue In Earnest
Tuesday, June 13, 2017 - 3:59pm | 407Read More...It’s going to be busy this week in the healthcare industry, with several key developments on the schedule that could have a major impact on the U.S. healthcare sector. What A Week First, on Monday, the Centers for Medicare and Medicaid Services released the latest batch of Health Insurance...
-
Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price
Monday, November 14, 2016 - 5:57pm | 291Read More...Gilead Sciences, Inc. (NASDAQ: GILD) recently reported a Q3 EPS miss, driven by lower than expected sales of its hepatitis C drugs Harvoni and Sovaldi. The poor performance may have been in response to increasing competition from companies like AbbVie Inc (NYSE: ABBV) and Merck & Co., Inc. (...
-
CMS Rate Hike: Which Stocks To Watch?
Tuesday, February 23, 2016 - 11:41am | 406Read More...Shares of health insurers climbed Monday after Centers for Medicare and Medicaid Services (CMS) proposed to increase the Baseline Medicare Advantage payment rates for 2017 by 1.35 percent, on average. Enrollment have grown in Medicare Advantage and Part D since enactment of the Affordable Care...
-
3 Medical Tech Trading Ideas With Upcoming Catalysts
Tuesday, September 29, 2015 - 9:34am | 560Read More...Caroline Corner, an analyst at Cantor Fitzgerald that covers medical technology highlighted three companies with upcoming catalysts. The three names are: Alimera Sciences Inc (NASDAQ: ALIM), Cerus Corporation (NASDAQ: CERS), and Intersect ENT Inc (NASDAQ: XENT). Corner stated all three...
-
New Proposed Home Health Rules Helps 'Big Guys,' Boosts M&A Outlook, SunTrust Says
Tuesday, July 7, 2015 - 12:16pm | 362Read More...The Centers for Medicare and Medicaid Services (CMS) released this week its proposed 2016 home health reimbursement rule that includes the industry's annual update and a framework for the implementation of value based purchasing. The proposal is calling for a 1.8 percent cut in 2016, 1.72 percent...
-
This Company Wants To Trade EKG Electrodes For A Smart Shirt
Wednesday, April 15, 2015 - 2:34pm | 974Read More...In the second part of a two-part interview with Noble Biomaterials CEO Jeff Keane, the executive discussed the potential ramifications of the use of Noble's X-static anti-microbial and soft-surface conductivity technology in healthcare. Read part one of the interview here. It begins, Keane...
-
How to Profit from Exploding Government Healthcare Costs
Thursday, July 28, 2011 - 9:37am | 576Read More...A report released on Thursday predicts that government spending on healthcare will rise dramatically over the next decade. Despite all the talk in Washington about cutting hundreds of billions of dollars in annual spending in order to reduce the deficit, the government's share of the national...
-
Bank Of America Reports On Sanction Removed From AET
Tuesday, June 14, 2011 - 8:37am | 147Read More...Bank of America is maintaining its Neutral rating and its $48 price target on Aetna (NYSE: AET) following news that CMS has removed the Medicare sanction from the company. In the report, Bank of America writes, “After the close, AET announced that CMS has lifted its Medicare marketing and...
-
Oppenheimer Reports On 2012 Medicare Advantage Rates
Tuesday, April 5, 2011 - 7:50am | 61Read More...Oppenheimer has issued a report following the announcement of the Medicare Advantage Rates for 2012. According to the report, "CMS released the FY2012 rate announcement, which would have a net effect of +0.4%, compared to +1.6% in the 45-day notice released in mid-February. The primary reason for...
